Skip to main content

Find Clinical Trials

Home
Conditions
MET Activating Mutation

Clinical trial condition

MET Activating Mutation

Explore clinical trials studying MET Activating Mutation. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

MET Activating Mutation trial results

Not Yet Recruiting

Bozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung Cancer

NCT07153770

Conditions: MET Activating Mutation, MET Exon 14 Mutation, NSCLC
Locations: Not specified

View Trial Details

Completed

Study of Crizotinib for ROS1 and MET Activated Lung Cancer

NCT04084717

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details